SGHT

Sight Sciences, Inc. - Common Stock (SGHT)

About Sight Sciences, Inc. - Common Stock (SGHT)

Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.

Details

Daily high
$3.61
Daily low
$3.50
Price at open
$3.59
52 Week High
$8.45
52 Week Low
$2.03
Market cap
181.0M
Dividend yield
0.00%
Volume
92,385
Avg. volume
161,981
P/E ratio
-3.59

Sight Sciences, Inc. - Common Stock News

Details

Daily high
$3.61
Daily low
$3.50
Price at open
$3.59
52 Week High
$8.45
52 Week Low
$2.03
Market cap
181.0M
Dividend yield
0.00%
Volume
92,385
Avg. volume
161,981
P/E ratio
-3.59